North America Adalimumab Market Growth Outlook Supported by...

adicionou um novo artigo Outro

2026-02-18 06:49:30

North America Adalimumab Market Growth Outlook Supported by Biologics Demand & Autoimmune Treatment Expansion

"In-Depth Study on Executive Summary North America Adalimumab Market Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the adalimumab market in the forecast period 2023-2030. The expected CAGR of adalimumab market is tend to be around 5.40 % in the mentioned forecast period. The market was valued at USD 16,879.8 million in 2022, and it would grow upto USD...

0 Comentários 0 Compartilhamentos 52 Visualizações 0 Anterior